| Class 2 Device Recall Blood Agar (TSA with 5 Sheep Blood) | |
Date Initiated by Firm | March 24, 2017 |
Date Posted | April 27, 2017 |
Recall Status1 |
Terminated 3 on June 06, 2017 |
Recall Number | Z-1888-2017 |
Recall Event ID |
76846 |
Product Classification |
Culture media, non-selective and differential - Product Code JSH
|
Product | Blood Agar (TSA w/ 5% Sheep Blood) Plate, For In Vitro Diagnostic Use, Remel, Lenexa, KS 66215
Product Usage:
Blood Agar is a solid medium recommended for use in qualitative procedures for the cultivation of a wide variety of microorganisms and visualization of hemolytic reactions. |
Code Information |
101686 |
Recalling Firm/ Manufacturer |
Remel Inc 12076 Santa Fe Trail Dr Lenexa KS 66215-3519
|
For Additional Information Contact | Gary Klaassen 913-895-4077 |
Manufacturer Reason for Recall | Confirmed complaint of surface contamination of Listeria monocytogenes. |
FDA Determined Cause 2 | Material/Component Contamination |
Action | On 3/24/2017, the recalling firm sent a recall notice to their customers explaining the reason for the recall and instructing customers to review their stock and discard any affected product. The notice also instructed customers to advise of the recall anyone they may have further distributed the recalled lot to. Attached to the recall notice is a response form which the recalling firm instructed their consignees to fill out and return. |
Quantity in Commerce | 1,159/100 plates/packs |
Distribution | US Nationwide distribution in the states of : AR, AZ, CO, IA, IL, KS, KY, LA, MI, MO, MS, MT, NC, ND, NE, NM, OH, OK, SD, and TX and Puerto Rico |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|